BusinessProQR Announces Positive Top-Line Results from a Phase 1b Study of QR-010 in Subjects with Cystic FibrosisBy Nasdaq OMXSep 25, 2017, 8:00 PM UTC
BusinessProQR to present QR-010 data at the European Cystic Fibrosis Society Conference and provides an update on the ongoing Phase 1b trialBy Nasdaq OMXJun 8, 2017, 1:04 PM UTC
